|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Yasmin Werner at 2026-03-10 13:15
Sentiment: Positive
TLDR CARVYKTI Q4 net trade sales hit $555M, rising 66% year over year globally. U.S. sales reached $420M while international revenue tripled to $135M. Manufacturing capacity targets 20,000 doses with strong 97–99% success rates. Clinical data shows 50.4-month progression-free survival in key patients. Legend Biotech expects enterprise-wide profitability by 2026. Legend Biotech (LEGN) stock fell [...] The post Bio Legend (LEGN) Stock: CARVYKTI Drives 66% Q4 Sales Surge and 2026 Profitability Outlook appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central